Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The global Next-Generation Sequencing market size is expected to reach US$ 17740 million by 2029, growing at a CAGR of 14.3% from 2023 to 2029. The market is mainly driven by the significant applications of Next-Generation Sequencing in various end use industries. The expanding demands from the Oncology, Hereditary Disease Detection and Life Science,, are propelling Next-Generation Sequencing market. Targeted Sequencing & Resequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at % CAGR for the next seven-year period.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next-Generation Sequencing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Next-Generation Sequencing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Next-Generation Sequencing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next-Generation Sequencing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Next-Generation Sequencing covered in this report include BGI, Illumina, Perkinelmer, Eurofins Scientific, Gatc Biotech, Macrogen, Qiagen, Genotypic Technology and Genewiz, etc.
The global Next-Generation Sequencing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Next-Generation Sequencing market, by region:
Global Next-Generation Sequencing market, Segment by Type:
Global Next-Generation Sequencing market, by Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Next-Generation Sequencing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Next-Generation Sequencing
1.1 Next-Generation Sequencing Market Overview
1.1.1 Next-Generation Sequencing Product Scope
1.1.2 Next-Generation Sequencing Market Status and Outlook
1.2 Global Next-Generation Sequencing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Next-Generation Sequencing Market Size by Region (2018-2029)
1.4 Global Next-Generation Sequencing Historic Market Size by Region (2018-2023)
1.5 Global Next-Generation Sequencing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Next-Generation Sequencing Market Size (2018-2029)
1.6.1 North America Next-Generation Sequencing Market Size (2018-2029)
1.6.2 Europe Next-Generation Sequencing Market Size (2018-2029)
1.6.3 Asia-Pacific Next-Generation Sequencing Market Size (2018-2029)
1.6.4 Latin America Next-Generation Sequencing Market Size (2018-2029)
1.6.5 Middle East & Africa Next-Generation Sequencing Market Size (2018-2029)
2 Next-Generation Sequencing Market by Type
2.1 Introduction
2.1.1 Targeted Sequencing & Resequencing
2.1.2 Whole Genome Sequencing
2.1.3 Whole Exome Sequencing
2.2 Global Next-Generation Sequencing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Next-Generation Sequencing Historic Market Size by Type (2018-2023)
2.2.2 Global Next-Generation Sequencing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Next-Generation Sequencing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Next-Generation Sequencing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Next-Generation Sequencing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Next-Generation Sequencing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Next-Generation Sequencing Revenue Breakdown by Type (2018-2029)
3 Next-Generation Sequencing Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Hereditary Disease Detection
3.1.3 Life Science
3.2 Global Next-Generation Sequencing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Next-Generation Sequencing Historic Market Size by Application (2018-2023)
3.2.2 Global Next-Generation Sequencing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Next-Generation Sequencing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Next-Generation Sequencing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Next-Generation Sequencing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Next-Generation Sequencing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Next-Generation Sequencing Revenue Breakdown by Application (2018-2029)
4 Next-Generation Sequencing Competition Analysis by Players
4.1 Global Next-Generation Sequencing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next-Generation Sequencing as of 2022)
4.3 Date of Key Players Enter into Next-Generation Sequencing Market
4.4 Global Top Players Next-Generation Sequencing Headquarters and Area Served
4.5 Key Players Next-Generation Sequencing Product Solution and Service
4.6 Competitive Status
4.6.1 Next-Generation Sequencing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BGI
5.1.1 BGI Profile
5.1.2 BGI Main Business
5.1.3 BGI Next-Generation Sequencing Products, Services and Solutions
5.1.4 BGI Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.1.5 BGI Recent Developments
5.2 Illumina
5.2.1 Illumina Profile
5.2.2 Illumina Main Business
5.2.3 Illumina Next-Generation Sequencing Products, Services and Solutions
5.2.4 Illumina Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.2.5 Illumina Recent Developments
5.3 Perkinelmer
5.3.1 Perkinelmer Profile
5.3.2 Perkinelmer Main Business
5.3.3 Perkinelmer Next-Generation Sequencing Products, Services and Solutions
5.3.4 Perkinelmer Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.3.5 Eurofins Scientific Recent Developments
5.4 Eurofins Scientific
5.4.1 Eurofins Scientific Profile
5.4.2 Eurofins Scientific Main Business
5.4.3 Eurofins Scientific Next-Generation Sequencing Products, Services and Solutions
5.4.4 Eurofins Scientific Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.4.5 Eurofins Scientific Recent Developments
5.5 Gatc Biotech
5.5.1 Gatc Biotech Profile
5.5.2 Gatc Biotech Main Business
5.5.3 Gatc Biotech Next-Generation Sequencing Products, Services and Solutions
5.5.4 Gatc Biotech Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.5.5 Gatc Biotech Recent Developments
5.6 Macrogen
5.6.1 Macrogen Profile
5.6.2 Macrogen Main Business
5.6.3 Macrogen Next-Generation Sequencing Products, Services and Solutions
5.6.4 Macrogen Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.6.5 Macrogen Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Next-Generation Sequencing Products, Services and Solutions
5.7.4 Qiagen Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Genotypic Technology
5.8.1 Genotypic Technology Profile
5.8.2 Genotypic Technology Main Business
5.8.3 Genotypic Technology Next-Generation Sequencing Products, Services and Solutions
5.8.4 Genotypic Technology Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.8.5 Genotypic Technology Recent Developments
5.9 Genewiz
5.9.1 Genewiz Profile
5.9.2 Genewiz Main Business
5.9.3 Genewiz Next-Generation Sequencing Products, Services and Solutions
5.9.4 Genewiz Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.9.5 Genewiz Recent Developments
5.10 Dna Link
5.10.1 Dna Link Profile
5.10.2 Dna Link Main Business
5.10.3 Dna Link Next-Generation Sequencing Products, Services and Solutions
5.10.4 Dna Link Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.10.5 Dna Link Recent Developments
5.11 Takara
5.11.1 Takara Profile
5.11.2 Takara Main Business
5.11.3 Takara Next-Generation Sequencing Products, Services and Solutions
5.11.4 Takara Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.11.5 Takara Recent Developments
5.12 Scigenom Labs
5.12.1 Scigenom Labs Profile
5.12.2 Scigenom Labs Main Business
5.12.3 Scigenom Labs Next-Generation Sequencing Products, Services and Solutions
5.12.4 Scigenom Labs Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.12.5 Scigenom Labs Recent Developments
5.13 Novogene
5.13.1 Novogene Profile
5.13.2 Novogene Main Business
5.13.3 Novogene Next-Generation Sequencing Products, Services and Solutions
5.13.4 Novogene Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.13.5 Novogene Recent Developments
5.14 Personalis
5.14.1 Personalis Profile
5.14.2 Personalis Main Business
5.14.3 Personalis Next-Generation Sequencing Products, Services and Solutions
5.14.4 Personalis Next-Generation Sequencing Revenue (US$ Million) & (2018-2023)
5.14.5 Personalis Recent Developments
6 North America
6.1 North America Next-Generation Sequencing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Next-Generation Sequencing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Next-Generation Sequencing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Next-Generation Sequencing Market Dynamics
11.1 Next-Generation Sequencing Industry Trends
11.2 Next-Generation Sequencing Market Drivers
11.3 Next-Generation Sequencing Market Challenges
11.4 Next-Generation Sequencing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research